• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • EoE Learning Hub
    • Bullous Pemphigoid Learning Hub
    • Chronic Spontaneous Urticaria Learning Hub
    • COPD Learning Hub
    • Rhinology Learning Hub
    • Type 2 Asthma Learning Hub
    • Prurigo Nodularis Learning Hub
    • Atopic Dermatitis Learning Hub
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: The NetherlandsChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Bullous pemphigoid
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
  • IL-33
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
Spotlight on Type 2 Inflammation in the Upper and Lower Airways
Pulmonology
4 min
expert video

Spotlight on Type 2 Inflammation in the Upper and Lower Airways

Compounded Burden of Co-existing Type 2 Airway Diseases
Pulmonology
4 min
expert video

Compounded Burden of Co-existing Type 2 Airway Diseases

Heterogeneous Presentation and Diagnosis in Bullous Pemphigoid
Dermatology
4 min
expert video

Heterogeneous Presentation and Diagnosis in Bullous Pemphigoid

Navigating Complex Definitions: Early Intervention and Disease Modification in Atopic Dermatitis
Dermatology
10 min
expert video

Navigating Complex Definitions: Early Intervention and Disease Modification in Atopic Dermatitis

Broadening the Lens: Clinical and Immunological Insights That Inform CSU Management
Dermatology
45 min
expert video

Broadening the Lens: Clinical and Immunological Insights That Inform CSU Management

Cumulative Impact of Uncontrolled Atopic Dermatitis: Skin Inflammation as the Tip of the Iceberg
Dermatology
10 min
expert video

Cumulative Impact of Uncontrolled Atopic Dermatitis: Skin Inflammation as the Tip of the Iceberg

Beyond Clinical Control: Targeting Type 2 Inflammation for Improved Patient Outcomes
Dermatology
10 min
expert video

Beyond Clinical Control: Targeting Type 2 Inflammation for Improved Patient Outcomes

Immunological Drivers in CSU: Diverse Pathways to Mast Cell Activation
Dermatology
10 min
expert video

Immunological Drivers in CSU: Diverse Pathways to Mast Cell Activation

Heterogeneity and Unpredictability: Challenges With the Diagnosis and Evaluation of CSU
Dermatology
10 min
expert video

Heterogeneity and Unpredictability: Challenges With the Diagnosis and Evaluation of CSU

The Burden of a Lifetime: Can Disease Modification Rewrite the Narrative of Atopic Dermatitis?
Dermatology
45 min
expert video

The Burden of a Lifetime: Can Disease Modification Rewrite the Narrative of Atopic Dermatitis?

Emerging Therapeutics: Addressing the Gaps in CSU Patient Care
Dermatology
10 min
expert video

Emerging Therapeutics: Addressing the Gaps in CSU Patient Care

FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients
Pulmonology
3 min
Infographic

FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients

    1
    ...
    567
    ...
    29